Announced Thu, 7 May · 12:23 IST
Analyst Meet on 13th May 2026
Board & Shareholder Meetings View source PDF
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.4%1-day move
₹2422.20
prior close
₹2480.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.1+0.2+0.1+2.4+0.6+1.0-0.5-0.4-1.3-8.8-9.9-0.6—
Up moveDown movePending
AI summary
GlaxoSmithKline Pharmaceuticals has notified exchanges about a scheduled group meeting with investors and analysts on 13th May 2026. The meeting will be held digitally. This is a routine regulatory disclosure under SEBI Listing Regulations. The company states that only information already in public domain will be shared during the interaction. The date may be subject to change due to exigencies.
Likely market impact
This is a standard informational filing with no immediate impact on stock price. Retail investors should note that no new material information is expected from this meeting.